Adverum Biotechnologies, Inc. Increase (Decrease) in Accounts Receivable
Adverum Biotechnologies, Inc. reported Increase (Decrease) in Accounts Receivable of -$886.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2019-03-06
- Adverum Biotechnologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2017-12-31 was $0.00.
- Adverum Biotechnologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2017-09-30 was $0.00.
- Adverum Biotechnologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2017-06-30 was $0.00.
- Adverum Biotechnologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2017-03-31 was -$886.00K, a 232.63% decline year-over-year.
- Adverum Biotechnologies, Inc. increase (decrease) in accounts receivable for fiscal 2017 was -$886.00K, a 302.75% decline from fiscal 2016.
- Adverum Biotechnologies, Inc. increase (decrease) in accounts receivable for fiscal 2016 was $437.00K, a 7183.33% increase from fiscal 2015.
- Adverum Biotechnologies, Inc. increase (decrease) in accounts receivable for fiscal 2015 was $6.00K.
- Adverum Biotechnologies, Inc. increase (decrease) in accounts receivable for fiscal 2014 was -$8.00K, a 214.29% decline from fiscal 2013.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | -$886.00K 10-K · filed 2019-03-06 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | -$886.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$886.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$886.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $437.00K 10-K · filed 2018-03-06 | |||
| 2016-03-31 | $668.00K 10-Q · filed 2016-05-06 | |||
| 2015-12-31 | $6.00K 10-K · filed 2018-03-06 | |||
| 2014-12-31 | -$8.00K 10-K · filed 2017-03-09 | |||
| 2014-03-31 | $225.00K 10-Q · filed 2015-05-13 | $226.00K derived: sum of 2 quarters · filed 2016-03-04 | $223.00K derived: sum of 3 quarters · filed 2016-03-04 | |
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | -$2.00K derived: sum of 2 quarters · filed 2016-03-04 | $7.00K 10-K · filed 2016-03-04 | |
| 2013-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $6.00K 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $9.00K 10-Q · filed 2014-09-12 |